Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry

Autor: Provencio, Mariano, Cobo, Manuel, Rodriguez-Abreu, Delvys, Carcereny, Enric, Cantero, Alexandra, Calvo, Virginia, López Castro, Rafael, Bernabé, Reyes, Bosch-Barrera, Joaquim, Massutí, Bartomeu, García Campelo, Rosario, Sánchez-Hernández, Alfredo, Laura Ortega, Ana, Guirado, Maria, del Barco, Edel, Camps, Carlos, Casal-Rubio, Joaquin, Dómine, Manuel, Angeles Sala, Mª, Padilla, Airam, Luís González Larriba, Jose, de Asís Aparisi, Francisco

Publikováno v: In Lung Cancer April 2024 190

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Determination of essential biomarkers in lung cancer: a real-world data study in Spain

Autor: Provencio Pulla, Mariano, Cobo, Manuel, Rodriguez-Abreu, Delvys, Calvo, Virginia, Carcereny, Enric, Cantero, Alejandra, Bernabé, Reyes, Benítez, Gretel, López Castro, Rafael, Massuti Sureda, Bartomeu, Barco, Edel, Garcia Campelo, Rosario, Guirado, Maria, Camps Herrero, Carlos, Ortega, Ana Laura, González Larriba, Jose Luís, Sánchez, Alfredo, Casal, Joaquín, Sala, M. Angeles, Juan Vidal, Óscar José, Bosch Barrera, Joaquim, Oramas, Juana, Dómine, Manuel, Trigo, Jose Manuel, Blanco, Remei, Calzas, Julia, Morilla, Idoia, Padilla, Airam, Torrente, Maria

Publikováno v: Provencio Pulla, Mariano Cobo, Manuel Rodriguez-Abreu, Delvys Calvo, Virginia Carcereny, Enric Cantero, Alejandra Bernabé, Reyes Benitez, Gretel López Castro, Rafael Massutí Sureda, Bartomeu Barco, Edel Garcia Campelo, Rosario Guirado, Maria Camps Herrero, Carlos Ortega, Ana Laura González Larriba, Jose Luís Sánchez, Alfredo Casal, Joaquín Sala, M. Angeles Juan Vidal, Oscar Bosch Barrera, Joaquim Oramas, Juana Dómine, Manuel Trigo, Jose Manuel Blanco, Remei Calzas, Julia Morilla, Idoia Padilla, Airam Torrente, Maria 2022 Determination of essential biomarkers in lung cancer: a real-world data study in Spain. BMC Cancer
RODERIC. Repositorio Institucional de la Universitat de Valéncia
instname

Background: The survival of patients with lung cancer has substantially increased in the last decade by about 15%. This increase is, basically, due to targeted therapies available for advanced stages and the emergence of immunotherapy itself. This wo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92afc14921aa8ba2b0c0f923d4f5ebe0
https://hdl.handle.net/10550/82667

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.